Elena Wolff‐Holz

Biosimilars: the science of extrapolation

Martina Weise, Pekka Kurki, Elena Wolff‐Holz et al. · Blood · 2014 · 295 citations · Full text

Pharmacy, Pharmacoeconomics, Regulatory Science +3

Interchangeability of Biosimilars: A European Perspective

Pekka Kurki, Leon van Aerts, Elena Wolff‐Holz et al. · BioDrugs · 2017 · 176 citations

Pharmacy, Translational Sciences, Bioequivalence +11

Equivalence of complex drug products: advances in and challenges for current regulatory frameworks

L. Hussaarts, Stefan Mühlebach, Vinod P. Shah et al. · Annals of the New York Academy of Sciences · 2017 · 88 citations · Full text

Pharmacy, Biotechnology, Pharmacology +17

Safety, Immunogenicity and Interchangeability of Biosimilar Monoclonal Antibodies and Fusion Proteins: A Regulatory Perspective

Pekka Kurki, Sean Barry, Ingrid Bourges et al. · Drugs · 2021 · 88 citations · Full text

Pharmacy, Immunology, Pharmacology +17

Identifiability of Biologicals in Adverse Drug Reaction Reports Received From European Clinical Practice

Niels S. Vermeer, Thijs J. Giezen, Sofia Zastavnik et al. · Clinical Pharmacology & Therapeutics · 2018 · 35 citations · Full text

Pharmacy, Pharmacology, Pharmaceutical Compliance +16